Literature DB >> 1638549

Transforming growth factor-beta.

J Massagué1, S Cheifetz, M Laiho, D A Ralph, F M Weis, A Zentella.   

Abstract

This chapter has described some of the most salient features of the biology of the TGF-beta s. The TGF-beta s are of great interest as growth inhibitors, regulators of cell phenotype and regulators of cell adhesion. The various TGF-beta isoforms are highly conserved and display a complex pattern of interactions with multiple membrane receptor components. Activation of these receptors leads to inhibition of epithelial cell proliferation by a mechanism that may involve proteins related to the growth suppressor, RB. TGF-beta receptors are also coupled to mechanisms that control expression of differentiation commitment genes and differentiated cell functions. TGF-beta can affect cell proliferation and differentiation through indirect mechanisms involving regulation of expression of cytokines, extracellular matrix molecules and their respective receptors. These responses strongly influence the growth and phenotype of an array of cell types. Excess or reduced TGF-beta activity may contribute to the pathogenesis of certain fibrotic disorders and certain hyperproliferative disorders including cancer, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638549

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  55 in total

Review 1.  Role of transforming growth factor Beta in corneal function, biology and pathology.

Authors:  A Tandon; J C K Tovey; A Sharma; R Gupta; R R Mohan
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

2.  Transforming growth factor-beta and multidrug resistance in chronic lymphocytic leukemia.

Authors:  W R Friedenberg; S A Salzman; S M Phan; J K Burmester
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

3.  Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme.

Authors:  W Götz; R Osmers; R Herken
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

4.  Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling.

Authors:  B A Hocevar; P H Howe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Controllable Soluble Protein Concentration Gradients in Hydrogel Networks.

Authors:  Brian J Peret; William L Murphy
Journal:  Adv Funct Mater       Date:  2008-11-01       Impact factor: 18.808

6.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

7.  Blockade of transforming growth factor-beta1 accelerates lymphatic regeneration during wound repair.

Authors:  Tomer Avraham; Sanjay Daluvoy; Jaime Zampell; Alan Yan; Yosef S Haviv; Stanley G Rockson; Babak J Mehrara
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

8.  A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.

Authors:  J M Slingerland; L Hengst; C H Pan; D Alexander; M R Stampfer; S I Reed
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor.

Authors:  Jennifer Sapitro; Jeffrey J Dunmire; Sarah E Scott; Vijay Sutariya; Werner J Geldenhuys; Michael Hewit; Beatrice Y J T Yue; Hiroshi Nakamura
Journal:  Mol Vis       Date:  2010-09-16       Impact factor: 2.367

10.  Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

Authors:  K Park; S J Kim; Y J Bang; J G Park; N K Kim; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.